Rusan Pharma has launched its new active pharmaceutical ingredient (API) facility in Pithampur, Madhya Pradesh. Strategically located within the Special Economic Zone (SEZ), the facility will have a production capability of 400 tonne of APIs annually. The total investment over two phases will be up to Rs 300 crore.

The new facility will enable Rusan to significantly enhance our existing API capacity and ensure the security of the supply of critical APIs to meet the growing demand for our addiction treatment and pain management products in India and globally. This API unit is designed to meet stringent international regulatory guidelines, ensuring the highest level of compliance.

The company's new plant boasts five modular API manufacturing blocks with dedicated suites for finished API manufacturing. This grants it complete control over the quality of its products and reduces its dependency on imports.

The new facility will capitalise on the support and subsidies provided by the Madhya Pradesh state government. This central location will streamline business operations and export processes through the dry port.